Arca
Skip to content
Tools
Tools

Betimol (timolol ophthalmic solution) 0.5%

Recall D-0374-2024, part of FDA recall event 94146. See Thea Pharma's company page.

Thea Pharma, Inc. started this Class II drug recall on Mar 5, 2024 (voluntary: firm initiated); FDA lists it as terminated, terminated Jun 30, 2025.

  • Classification: Class II
  • Started: Mar 5, 2024
  • Status: Terminated

Why It Was Recalled

Class II

Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

Record

Product
Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15
Quantity
5,476 bottles
Lots and codes
Lot #: 435019, Exp. Date 11/2024
Distribution
Product was distributed nationwide within the United States
Recalling firm
Thea Pharma, Inc., Waltham, MA, United States
How the firm notified
Letter
FDA classified
Mar 11, 2024

Thea Pharma, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.